Ezetimibe
Showing 1 - 25 of 429
Hyperlipidemias Trial in Qingdao (ezetimibe tablet, ezetimibe tablet(Ezetrol ®))
Completed
- Hyperlipidemias
- ezetimibe tablet
- ezetimibe tablet(Ezetrol ®)
-
Qingdao, Shandong, ChinaClinical Research Center
Dec 27, 2022
Healthy Volunteer Study Trial (Fixed-Dose Combination (FDC) Tablet)
Not yet recruiting
- Healthy Volunteer Study
- Fixed-Dose Combination (FDC) Tablet
- (no location specified)
Sep 22, 2023
Dyslipidemias, Hypercholesterolemia, Familial Hypercholesterolemia Trial (combination product, drug, other)
Not yet recruiting
- Dyslipidemias
- +4 more
- Combination Therapy
- +5 more
- (no location specified)
Aug 22, 2023
Healthy Lactating Women Trial in Las Vegas (Bempedoic Acid 180 MG Oral Tablet, Bempedoic Acid/Ezetimibe 180 MG-10 MG Oral
Recruiting
- Healthy Lactating Women
- Bempedoic Acid 180 MG Oral Tablet
- Bempedoic Acid/Ezetimibe 180 MG-10 MG Oral Tablet
-
Las Vegas, NevadaPPD Development, Las Vegas Research Unit
Aug 27, 2023
Coronary Artery Calcification, Metabolic Syndrome, Dyslipidemias Trial (Guideline directed statin therapy, High intensity statin
Not yet recruiting
- Coronary Artery Calcification
- +2 more
- Guideline directed statin therapy
- High intensity statin plus ezetimibe therapy
- (no location specified)
Apr 25, 2023
Coronary Artery Disease Requiring Coronary Revascularization With Newer Generation DES Implantation Trial in Seoul
Not yet recruiting
- Coronary Artery Disease Requiring Coronary Revascularization With Newer Generation DES Implantation
- ezetimibe/high-intensity statin combination therapy (ezetimibe 10mg plus atoravastatin 40mg)
- high-intensity statin monotherapy (atoravastatin 40mg)
-
Seoul, Korea, Republic ofYonsei University Health System, Severance Hospital
Mar 21, 2023
Bempedoic Acid And/Or Its Fixed-dose Combination With Ezetimibe
Not yet recruiting
- Primary Hypercholesterolemia
- Mixed Dyslipidemia
- Bempedoic acid and/or its fixed dose combination with ezetimibe
- (no location specified)
Mar 23, 2023
Dyslipidemias, Stroke, Acute Ischemic Trial in Ansan, Seoul (combination of high-dose rosuvastatin and ezetimibe, high-dose
Recruiting
- Dyslipidemias
- Stroke, Acute Ischemic
- combination of high-dose rosuvastatin and ezetimibe
- high-dose rosuvastatin single administration
-
Ansan, Gyeonggi-do, Korea, Republic of
- +2 more
May 22, 2023
Diabetes, Pre Diabetes, ASCVD Trial (high-intensity statin arm, low-intensity statin plus ezetimibe)
Not yet recruiting
- Diabetes Mellitus
- +2 more
- high-intensity statin arm
- low-intensity statin plus ezetimibe
- (no location specified)
Oct 12, 2022
Atherosclerotic Cardiovascular Disease Trial (Atozet 10/40 mg or 10/80 mg, Lipitor 40 mg or 80 mg)
Not yet recruiting
- Atherosclerotic Cardiovascular Disease
- Atozet 10/40 mg or 10/80 mg
- Lipitor 40 mg or 80 mg
- (no location specified)
Mar 8, 2023
Status of Dyslipidemia Following Administration of Statin and
Recruiting
- Dyslipidemias
- Statin+Ezetimibe compound
-
Seoul, Korea, Republic ofKorea University Guro Hospital
Nov 7, 2022
Coronary Artery Disease, Dyslipidemias Trial in Yongin (a high dose of statin/ezetimib)
Recruiting
- Coronary Artery Disease
- Dyslipidemias
- a high dose of statin/ezetimib
-
Yongin, Gyeonggi-do, Korea, Republic ofYongin Severance Hospital
Jun 14, 2023
Metabolic Syndrome Trial in Houston (Simvastatin, Vytorin, Placebo)
Completed
- Metabolic Syndrome
- Simvastatin
- +3 more
-
Houston, TexasBaylor College of Medicine
Jul 21, 2022
Efficacy of Fixed Dose Combination Therapy With Atorvastatin and
Enrolling by invitation
- Primary Hypercholesterolemia
-
Seoul, Korea, Republic ofSeverance Hospital, Yonsei University Health System
Nov 4, 2022
Chronic Hepatitis C Trial in Hines (20mg ezetimibe, Placebo, 40mg ezetimibe)
Terminated
- Chronic Hepatitis C
- 20mg ezetimibe
- +2 more
-
Hines, IllinoisEdward Hines Jr. VA Hospital, Hines, IL
May 10, 2022
Dyslipidemias, Atherosclerotic Cardiovascular Disease Trial in Seoul (Pitavastatin, Pitavastatin plus Ezetemibe, Atorvastatin)
Not yet recruiting
- Dyslipidemias
- Atherosclerotic Cardiovascular Disease
- Pitavastatin
- +2 more
-
Seoul, Korea, Republic ofYonsei University Health System, Severance Hospital
Jan 29, 2023
Ezetimibe-Rosuvastatin Evaluation Study
Not yet recruiting
- Hypercholesterolemia
- +2 more
-
Athens, GreeceAthens University Hospital
May 19, 2022
Dyslipidemias, High Cholesterol, Hypercholesterolemia Trial in United States (Obicetrapib, Ezetimibe 10mg, Obicetrapib )
Active, not recruiting
- Dyslipidemias
- +2 more
- Obicetrapib
- +3 more
-
Gardena, California
- +6 more
Jul 14, 2022
Primary Hypercholesterolemia Trial (Ezetimibe, Atorvastatin, Rosuvastatin)
Completed
- Primary Hypercholesterolemia
- Ezetimibe
- +2 more
- (no location specified)
Feb 7, 2022
Myocardial Infarction, Statin Adverse Reaction, HMG-CoA Reductase Inhibitor Toxicity Trial in Korea, Republic of (Rosuzet 10/5
Recruiting
- Myocardial Infarction
- +2 more
- Ezetimibe 10mg + Rosuvastatin 5mg
- Rosuvastatin 20mg
-
Bucheon, Gyeonggido, Korea, Republic of
- +6 more
Sep 2, 2022
Diabetes, Type 2 Trial in Hong Kong (Simvastatin 10mg, Ezetimibe 10mg)
Enrolling by invitation
- Diabetes Mellitus, Type 2
- Simvastatin 10mg
- Ezetimibe 10mg
-
Hong Kong, Hong KongDiabetes Centre, 2/F, Block L, Department of Medicine, Queen Mar
Nov 21, 2022
Vytorin Tablet Among Filipino Patients
Completed
- Hypercholesterolemia
- Vytorin (R) (Ezetimibe + Simvastatin)
- (no location specified)
Feb 7, 2022